Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of Clarinex

Schering-Plough Corporation today announced an agreement with Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc., related to the generic manufacturing of certain formulations of CLARINEX (desloratadine).

The details can be read here.